GlassScriptPhysician profile
David K Kung
NPI 1114134921
$11,986.98
in general payments reported to CMS, 2019-2025
16 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,868 · 2020: $694 · 2021: $352 · 2022: $2,834 · 2023: $1,562 · 2024: $656 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,648 · Travel and Lodging: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,647.74 |
| Travel and Lodging | $590.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $5,211.39 | 2019-2025 | Smart Coil, Penumbra System, Red 72 |
| Stryker Corporation | $1,575.28 | 2019-2024 | Trevo, Evolve Proline, Axs Vecta 71 |
| Orthofix Medical, INC. | $1,417.47 | 2022 | |
| Medical Device Business Services, INC. | $1,093.18 | 2022 | |
| Imperative Care, INC | $851.41 | 2023-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Rapid Medical LTD | $450.07 | 2022-2024 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Clariance, INC. | $342.92 | 2023 | Erisma-LP, Idys-Tlif 3dti, Idys-Alif |
| Depuy Synthes Sales INC. | $181.25 | 2021-2023 | Embotrap |
| Nuvasive, INC. | $159.19 | 2022 | |
| Medtronic, INC. | $156.29 | 2021-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology |
| Qapel Medical INC | $139.60 | 2023 | |
| Balt USA, LLC | $134.87 | 2023 | |
| Portola Pharmaceuticals, LLC | $125.00 | 2019 | |
| Surgalign Spine Technologies, INC. | $96.57 | 2020 | |
| Zimmer Biomet Holdings, INC. | $31.66 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20.83 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.